These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 36821759)
21. Efficacy of a heparin removal device in comparison with protamine after hypothermic cardiopulmonary bypass. Tao W; Deyo DJ; Brunston RL; Vertrees RA; Grochoske TL; Zwischenberger JB ASAIO J; 1997; 43(5):M825-30. PubMed ID: 9360162 [TBL] [Abstract][Full Text] [Related]
22. Anticoagulation and anticoagulation reversal with cardiac surgery involving cardiopulmonary bypass: an update. Despotis GJ; Joist JH J Cardiothorac Vasc Anesth; 1999 Aug; 13(4 Suppl 1):18-29; discussion 36-7. PubMed ID: 10468245 [TBL] [Abstract][Full Text] [Related]
23. Pilot study of the efficacy of a thrombin inhibitor for use during cardiopulmonary bypass. DeAnda A; Coutre SE; Moon MR; Vial CM; Griffin LC; Law VS; Komeda M; Leung LL; Miller DC Ann Thorac Surg; 1994 Aug; 58(2):344-50. PubMed ID: 8067830 [TBL] [Abstract][Full Text] [Related]
24. Anticoagulation for cardiac surgery in patients receiving preoperative heparin: use of the high-dose thrombin time. Shore-Lesserson L; Manspeizer HE; Bolastig M; Harrington D; Vela-Cantos F; DePerio M Anesth Analg; 2000 Apr; 90(4):813-8. PubMed ID: 10735781 [TBL] [Abstract][Full Text] [Related]
25. Effect of combined anticoagulation using heparin and bivalirudin on the hemostatic and inflammatory responses to cardiopulmonary bypass in the rat. Welsby IJ; Jones WL; Arepally G; De Lange F; Yoshitani K; Phillips-Bute B; Grocott HP; Becker R; Mackensen GB Anesthesiology; 2007 Feb; 106(2):295-301. PubMed ID: 17264724 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of factor IXa by the pegnivacogin system during cardiopulmonary bypass: a potential substitute for heparin. A study in baboons. Bel A; Borik W; Davidson S; Helies JM; Stimmer L; Fremes S; Zelenkofske S; Rusconi C; Alexander J; Alexander D; Menasché P; Pepper J Eur J Cardiothorac Surg; 2016 Feb; 49(2):682-9. PubMed ID: 25953802 [TBL] [Abstract][Full Text] [Related]
27. Monitoring activated clotting time for combined heparin and aprotinin application: in vivo evaluation of a new aprotinin-insensitive test using Sonoclot. Ganter MT; Monn A; Tavakoli R; Genoni M; Klaghofer R; Furrer L; Honegger H; Hofer CK Eur J Cardiothorac Surg; 2006 Aug; 30(2):278-84. PubMed ID: 16828293 [TBL] [Abstract][Full Text] [Related]
28. Investigation of a thrombin inhibitor peptide as an alternative to heparin in cardiopulmonary bypass surgery. Chomiak PN; Walenga JM; Koza MJ; Reilly TM; Turlapathy P; Pifarre R Circulation; 1993 Nov; 88(5 Pt 2):II407-12. PubMed ID: 7993389 [TBL] [Abstract][Full Text] [Related]
29. Bivalirudin Anticoagulation for a Pediatric Patient with Heparin-Induced Thrombocytopenia and Thrombosis Requiring Cardiopulmonary Bypass for Ventricular Assist Device Placement. Faella KH; Whiting D; Fynn-Thompson F; Matte GS J Extra Corpor Technol; 2016 Mar; 48(1):39-42. PubMed ID: 27134308 [TBL] [Abstract][Full Text] [Related]
30. Ancrod (Arvin) as an alternative to heparin anticoagulation for cardiopulmonary bypass. Zulys VJ; Teasdale SJ; Michel ER; Skala RA; Keating SE; Viger JR; Glynn MF Anesthesiology; 1989 Dec; 71(6):870-7. PubMed ID: 2589675 [TBL] [Abstract][Full Text] [Related]
31. Patients with a history of type II heparin-induced thrombocytopenia with thrombosis requiring cardiac surgery with cardiopulmonary bypass: a prospective observational case series. Nuttall GA; Oliver WC; Santrach PJ; McBane RD; Erpelding DB; Marver CL; Zehr KJ Anesth Analg; 2003 Feb; 96(2):344-50, table of contents. PubMed ID: 12538175 [TBL] [Abstract][Full Text] [Related]
32. Maintenance of blood heparin concentration rather than activated clotting time better preserves the coagulation system in hypothermic cardiopulmonary bypass. Shirota K; Watanabe T; Takagi Y; Ohara Y; Usui A; Yasuura K Artif Organs; 2000 Jan; 24(1):49-56. PubMed ID: 10677157 [TBL] [Abstract][Full Text] [Related]
34. Recombinant hirudin as an alternative for anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II: a 1-year experience in 57 patients. Koster A; Hansen R; Kuppe H; Hetzer R; Crystal GJ; Mertzlufft F J Cardiothorac Vasc Anesth; 2000 Jun; 14(3):243-8. PubMed ID: 10890473 [TBL] [Abstract][Full Text] [Related]
35. Recombinant hirudin for cardiopulmonary bypass anticoagulation: a randomized, prospective, and heparin-controlled pilot study. Riess FC; Poetzsch B; Madlener K; Cramer E; Doll KN; Doll S; Lorke DE; Kormann J; Mueller-Berghaus G Thorac Cardiovasc Surg; 2007 Jun; 55(4):233-8. PubMed ID: 17546553 [TBL] [Abstract][Full Text] [Related]